Stem cell shots aim to shield frontline workers from COVID-19
NCT ID NCT04348435
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tested whether five infusions of stem cells (HB-adMSCs) could prevent COVID-19 symptoms and hospitalizations in 53 high-risk workers like doctors and firefighters. Participants had no signs of COVID-19 at the start. The goal was to see if the stem cells could boost the immune system and keep people from getting sick.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.